IgG Subclass Deficiency in IBD Patients

Diagnostic Considerations

Approximately 2.5% of healthy individuals naturally have levels below the normal range for at least one IgG subclass, but this baseline rate is clearly exceeded in IBD populations, highlighting the importance of measuring IgG subclasses in patients with recurrent infections despite adequate IBD treatment 1
Normal total IgG does not exclude clinically significant IgG subclass deficiency, particularly IgG4 deficiency which is distinct from other antibody deficiencies, and medication effects must be considered when interpreting results 1
Abnormal subclass levels should be confirmed with repeat testing at least one month apart before making clinical decisions, and the American College of Gastroenterology recommends considering IgG subclass measurement in patients with unexplained severe or refractory disease course 1, 2

When IgG subclass abnormalities are identified, assess specific antibody responses to pneumococcal polysaccharide vaccine and evaluate protein antigen responses, with a protective response defined as concentration >1.3 mg/mL for >70% of serotypes tested 2, 3

For IgG4-deficient IBD patients with severe disease, standard IgG replacement dosing is 400 mg/kg every 28 days when indicated, though optimal dosing in IBD has not been established in controlled trials, and the American Gastroenterological Association suggests that IgG replacement should not be initiated based solely on laboratory values without clinical correlation 1